e-Drug3D 1083 |
DIGITOXIN DISCONTINUED
|
cas 71-63-6 |
CLASS CARDIOVASCULAR |
ROUTE (list) INJECTION |
ATC code |
PK parameters F 70 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET SODIUM-POTASSIUM ATPASE PDB Ligand code = F9R (link to the list of PDB complexes) Download experimental 3D coordinates of F9R with added hydrogens |
DrugCentral Sodium,potassium-transporting ATPase subunit alpha-1 UNIPROT P05023 ATP1A1 |
Download SDF file | 4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one Formula: Calculated chemical properties: MW 764.92 NB_atoms 54 XLogP 3.25 PSA 175.963 NB_HD 5 NB_HA 13 fsp3 0.93 Lipinski(0=no;1=yes) 0 |
FDA NDA 084100 (pdf not found) INN (DIGITOXIN) CRYSTODIGIN (LILLY) APPROVAL= AP YEAR= 1978 DISCONTINUED |
Other links: |